The European Food Safety Authority (EFSA; Parma, Italy) has issued positive opinions for the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) for eye, brain, and heart health.
The European Food Safety Authority (EFSA; Parma, Italy) has issued positive opinions for the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), according to reports from DSM Nutritional Products (Parsippany, NJ), which provided some of the supporting science.
Health claims submitted through EU member states led to the following variety of positive opinions which could ultimately become authorized health claims in the EU:
DSM expects the European Commission to approve health claims for DHA and EPA based on the positive opinions, the company stated.
DHA is receiving greater attention due to recent science suggesting a variety of health benefits from the nutrient and a weak conversion rate of alpha linolenic acid (ALA) omega-3 to DHA.
To read DSM’s coverage of the news, click here.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.